• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肱踝脉搏波速度可预测常染色体显性多囊肾病患者的肝脏体积。

Brachial-ankle pulse wave velocity predicts liver volume in patients with autosomal dominant polycystic kidney disease.

作者信息

Tato Wasako, Suwabe Tatsuya, Ubara Yoshifumi, Oba Yuki, Mizuno Hiroki, Ikuma Daisuke, Yamanouchi Masayuki, Inoue Noriko, Sekine Akinari, Tanaka Kiho, Hasegawa Eiko, Wada Takehiko, Sawa Naoki

机构信息

Department of Nephrology, Toranomon Hospital Kajigaya, Kawasaki, Japan.

Department of Nephrology, Nara Medical University, Kashihara, Japan.

出版信息

PLoS One. 2025 Jul 21;20(7):e0328133. doi: 10.1371/journal.pone.0328133. eCollection 2025.

DOI:10.1371/journal.pone.0328133
PMID:40690501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12279127/
Abstract

BACKGROUND

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease and Polycystic liver disease (PLD) is the most common extrarenal manifestation of ADPKD. Various non-inherited factors have been reported to affect total kidney volume (TKV) in ADPKD. However, the non-inherited factors affecting liver volume (LV) in ADPKD are unknown.

METHODS

We aimed to identify the factors affecting LV and TKV in ADPKD; and to analyze the relationship between changes in these parameters and arterial stiffness, assessed using brachial-ankle pulse wave velocity (baPWV).

RESULTS

We enrolled 165 patients (66 men and 99 women; mean age 47.3 ± 6.9 years). Univariable analysis revealed that sex, mean baPWV, ΔbaPWV, tolvaptan use, hyperlipidemia, hyperuricemia, Hb concentration, eGFR, proteinuria, and height-adjusted TKV (htTKV) were significantly associated with height-adjusted LV (htLV) at baseline. Multivariate analysis showed that sex, BMI, ΔbaPWV, and tolvaptan use were significantly associated with htLV at baseline. The baseline htLV correlated with ΔbaPWV (r = 0.32, p < 0.0001). Univariable linear mixed model analysis revealed that sex, mean baPWV, ΔbaPWV, tolvaptan use, hyperuricemia, Hb concentration, eGFR, and proteinuria significantly affected the change in htLV. Multivariate linear mixed model analysis revealed that sex, BMI, and tolvaptan use significantly affected the change in htLV. The change in the htLV ratio was larger in patients with a higher ΔbaPWV (p < 0.0001). Whereas, ΔbaPWV was not a significant factor for the baseline htTKV and the changes in htTKV in univariable and multivariable analysis.

CONCLUSIONS

We have shown that ΔbaPWV is a predictor of baseline htLV, and the chronological changes in htLV in patients with ADPKD.

摘要

背景

常染色体显性遗传性多囊肾病(ADPKD)是最常见的遗传性肾病,多囊肝病(PLD)是ADPKD最常见的肾外表现。已有报道称多种非遗传因素会影响ADPKD患者的总肾体积(TKV)。然而,影响ADPKD患者肝脏体积(LV)的非遗传因素尚不清楚。

方法

我们旨在确定影响ADPKD患者LV和TKV的因素;并分析这些参数变化与使用肱踝脉搏波速度(baPWV)评估的动脉僵硬度之间的关系。

结果

我们纳入了165例患者(66例男性和99例女性;平均年龄47.3±6.9岁)。单变量分析显示,性别、平均baPWV、ΔbaPWV、托伐普坦使用情况、高脂血症、高尿酸血症、血红蛋白浓度、估算肾小球滤过率(eGFR)、蛋白尿以及身高校正后的TKV(htTKV)在基线时与身高校正后的LV(htLV)显著相关。多变量分析表明,性别、体重指数(BMI)、ΔbaPWV和托伐普坦使用情况在基线时与htLV显著相关。基线htLV与ΔbaPWV相关(r = 0.32,p < 0.0001)。单变量线性混合模型分析显示,性别、平均baPWV、ΔbaPWV、托伐普坦使用情况、高尿酸血症、血红蛋白浓度、eGFR和蛋白尿显著影响htLV的变化。多变量线性混合模型分析显示,性别、BMI和托伐普坦使用情况显著影响htLV的变化。ΔbaPWV较高的患者htLV比值变化更大(p < 0.0001)。而在单变量和多变量分析中,ΔbaPWV不是基线htTKV及htTKV变化的显著因素。

结论

我们已经表明,ΔbaPWV是ADPKD患者基线htLV以及htLV随时间变化的一个预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/12279127/366759c3f0b0/pone.0328133.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/12279127/921cfc3ad889/pone.0328133.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/12279127/cada32b2ff1b/pone.0328133.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/12279127/60befe5ba6b0/pone.0328133.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/12279127/779329f4837f/pone.0328133.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/12279127/024a6aeb1407/pone.0328133.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/12279127/c65001210620/pone.0328133.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/12279127/366759c3f0b0/pone.0328133.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/12279127/921cfc3ad889/pone.0328133.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/12279127/cada32b2ff1b/pone.0328133.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/12279127/60befe5ba6b0/pone.0328133.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/12279127/779329f4837f/pone.0328133.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/12279127/024a6aeb1407/pone.0328133.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/12279127/c65001210620/pone.0328133.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edd/12279127/366759c3f0b0/pone.0328133.g007.jpg

相似文献

1
Brachial-ankle pulse wave velocity predicts liver volume in patients with autosomal dominant polycystic kidney disease.肱踝脉搏波速度可预测常染色体显性多囊肾病患者的肝脏体积。
PLoS One. 2025 Jul 21;20(7):e0328133. doi: 10.1371/journal.pone.0328133. eCollection 2025.
2
Interventions for preventing the progression of autosomal dominant polycystic kidney disease.用于预防常染色体显性遗传性多囊肾病进展的干预措施。
Cochrane Database Syst Rev. 2024 Oct 2;10(10):CD010294. doi: 10.1002/14651858.CD010294.pub3.
3
Polycystic Kidney Disease, Autosomal Dominant常染色体显性多囊肾病
4
Renoprotective effects of combination therapy with tolvaptan and dapagliflozin in autosomal dominant polycystic kidney disease: a four-case series.托伐普坦与达格列净联合治疗常染色体显性多囊肾病的肾脏保护作用:四例病例系列报道
CEN Case Rep. 2025 Jun;14(3):500-506. doi: 10.1007/s13730-025-00990-7. Epub 2025 Apr 11.
5
The safety and efficacy of tolvaptan in the treatment of patients with autosomal dominant polycystic kidney disease: A systematic review and meta-analysis.托伐普坦治疗常染色体显性遗传性多囊肾病患者的安全性和有效性:一项系统评价和荟萃分析。
Nefrologia (Engl Ed). 2023 Nov-Dec;43(6):731-741. doi: 10.1016/j.nefroe.2023.04.002. Epub 2023 May 5.
6
Association between the triglyceride-glucose-waist-to-height ratio and early arterial stiffness in cardiovascular-kidney-metabolic syndrome.甘油三酯-血糖-腰高比与心血管-肾脏-代谢综合征早期动脉僵硬度之间的关联
Eur J Med Res. 2025 Jul 16;30(1):629. doi: 10.1186/s40001-025-02881-0.
7
The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regression.疾病严重程度标志物对常染色体显性多囊肾病患者生活质量的影响:一项系统评价、荟萃分析和荟萃回归分析
BMC Nephrol. 2017 May 25;18(1):169. doi: 10.1186/s12882-017-0578-6.
8
Automated devices for identifying peripheral arterial disease in people with leg ulceration: an evidence synthesis and cost-effectiveness analysis.用于识别下肢溃疡患者外周动脉疾病的自动化设备:证据综合和成本效益分析。
Health Technol Assess. 2024 Aug;28(37):1-158. doi: 10.3310/TWCG3912.
9
Arterial Stiffness and Subsequent Incidence of CKD and Kidney Function Decline in a Large Longitudinal Community Cohort: The Atherosclerosis in Communities (ARIC) Study.大型纵向社区队列中动脉僵硬度与慢性肾脏病的后续发病率及肾功能下降:社区动脉粥样硬化风险(ARIC)研究
Am J Kidney Dis. 2025 Jul;86(1):32-42. doi: 10.1053/j.ajkd.2024.11.011. Epub 2025 Jan 23.
10
Correlations between renal function and the total kidney volume measured on imaging for autosomal dominant polycystic kidney disease: A systematic review and meta-analysis.常染色体显性多囊肾病影像学测量的肾功能与总肾体积的相关性:系统评价和荟萃分析。
Eur J Radiol. 2017 Oct;95:56-65. doi: 10.1016/j.ejrad.2017.07.023. Epub 2017 Aug 1.

本文引用的文献

1
Acute renal intracystic hemorrhage in patients with autosomal dominant polycystic kidney disease.常染色体显性多囊肾病患者的急性肾内囊内出血。
J Nephrol. 2023 May;36(4):999-1010. doi: 10.1007/s40620-022-01562-z. Epub 2023 Feb 8.
2
Changes in Kidney and Liver Volumes in Patients With Autosomal Dominant Polycystic Kidney Disease Before and After Dialysis Initiation.常染色体显性多囊肾病患者开始透析前后肾脏和肝脏体积的变化
Mayo Clin Proc Innov Qual Outcomes. 2023 Jan 20;7(1):69-80. doi: 10.1016/j.mayocpiqo.2022.12.005. eCollection 2023 Feb.
3
Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease.
常染色体显性遗传多囊肾病早期多囊肝的体积进展和影像学分类。
Clin J Am Soc Nephrol. 2022 Mar;17(3):374-384. doi: 10.2215/CJN.08660621. Epub 2022 Feb 25.
4
Potential effect of tolvaptan on polycystic liver disease for patients with ADPKD meeting the Japanese criteria of tolvaptan use.托伐普坦对符合托伐普坦使用日本标准的 ADPKD 患者多囊性肝病的潜在影响。
PLoS One. 2022 Feb 17;17(2):e0264065. doi: 10.1371/journal.pone.0264065. eCollection 2022.
5
Autosomal Dominant Polycystic Kidney Disease in which the Polycystic Liver Volume Was Reduced by Rigorous Blood Pressure Control.常染色体显性遗传性多囊肾病患者,通过严格的血压控制降低多囊肝体积。
Intern Med. 2022 Jan 1;61(1):49-52. doi: 10.2169/internalmedicine.7441-21. Epub 2021 Jul 3.
6
Salt, water, and vasopressin in polycystic kidney disease.多囊肾病中的盐、水和血管加压素
Kidney Int. 2020 Oct;98(4):831-834. doi: 10.1016/j.kint.2020.06.001.
7
Autosomal dominant polycystic kidney disease.常染色体显性遗传性多囊肾病。
Lancet. 2019 Mar 2;393(10174):919-935. doi: 10.1016/S0140-6736(18)32782-X. Epub 2019 Feb 25.
8
Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease.超重和肥胖是常染色体显性遗传多囊肾病早期进展的预测因素。
J Am Soc Nephrol. 2018 Feb;29(2):571-578. doi: 10.1681/ASN.2017070819. Epub 2017 Nov 8.
9
Risk of aortic aneurysm and dissection in patients with autosomal-dominant polycystic kidney disease: a nationwide population-based cohort study.常染色体显性多囊肾病患者发生主动脉瘤和主动脉夹层的风险:一项基于全国人群的队列研究。
Oncotarget. 2017 Mar 17;8(34):57594-57604. doi: 10.18632/oncotarget.16338. eCollection 2017 Aug 22.
10
Brachial-Ankle Pulse Wave Velocity and the Risk Prediction of Cardiovascular Disease: An Individual Participant Data Meta-Analysis.肱踝脉搏波速度与心血管疾病风险预测的个体参与者数据荟萃分析。
Hypertension. 2017 Jun;69(6):1045-1052. doi: 10.1161/HYPERTENSIONAHA.117.09097. Epub 2017 Apr 24.